PRINCIPAL FINANCIAL GROUP INC - COHERUS BIOSCIENCES INC ownership

COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 95 filers reported holding COHERUS BIOSCIENCES INC in Q3 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of COHERUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$91,188
-94.6%
24,382
-93.8%
0.00%
-100.0%
Q2 2023$1,683,406
-38.8%
394,240
-2.0%
0.00%
-50.0%
Q1 2023$2,752,772
-15.6%
402,452
-2.2%
0.00%0.0%
Q4 2022$3,259,769
-21.4%
411,587
-4.6%
0.00%
-33.3%
Q3 2022$4,145,000
+21.6%
431,273
-8.4%
0.00%0.0%
Q2 2022$3,409,000
-46.2%
470,805
-4.1%
0.00%
-25.0%
Q1 2022$6,338,000
-23.6%
490,946
-5.5%
0.00%
-20.0%
Q4 2021$8,293,000
-19.8%
519,612
-19.2%
0.01%
-28.6%
Q3 2021$10,337,000
+13.1%
643,282
-2.7%
0.01%
+16.7%
Q2 2021$9,141,000
+12.3%
660,918
+18.6%
0.01%0.0%
Q1 2021$8,139,000
-14.4%
557,032
+1.8%
0.01%
-14.3%
Q4 2020$9,507,000
-10.8%
547,014
-5.9%
0.01%
-22.2%
Q3 2020$10,660,000
+12.1%
581,218
+9.2%
0.01%
+12.5%
Q2 2020$9,506,000
+1142.6%
532,265
+1028.7%
0.01%
+700.0%
Q1 2020$765,000
-8.7%
47,157
+1.4%
0.00%0.0%
Q4 2019$838,000
+282.6%
46,528
+330.1%
0.00%
Q3 2019$219,000
-6.8%
10,818
+1.7%
0.00%
Q2 2019$235,000
+62.1%
10,641
-0.1%
0.00%
Q1 2019$145,000
+26.1%
10,648
+2.3%
0.00%
Q1 2018$115,000
-94.3%
10,410
-92.6%
0.00%
-100.0%
Q2 2017$2,015,000
-31.2%
140,390
+1.4%
0.00%
-50.0%
Q1 2017$2,928,000138,4400.00%
Other shareholders
COHERUS BIOSCIENCES INC shareholders Q3 2017
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 650,000$10,374,0002.09%
CM Management, LLC 125,000$1,995,0001.51%
Perceptive Advisors 10,815,596$172,616,0001.33%
Bridge City Capital, LLC 163,198$2,605,0001.07%
Phocas Financial Corp. 514,438$8,210,0001.04%
Redwood Investments, LLC 709,184$11,319,0000.89%
Aristotle Capital Boston, LLC 2,087,187$33,312,0000.78%
Knott David M Jr 102,555$1,637,0000.56%
Zebra Capital Management LLC 16,746$267,0000.43%
Temasek Holdings (Private) Ltd 7,381,116$117,803,0000.42%
View complete list of COHERUS BIOSCIENCES INC shareholders